Medical Condition News

RSS

Poverty and obesity links

According to U.S. government researchers in a new report, women who are poor are much more likely to be obese but men are not. They revealed this Tuesday that where income does not greatly affect whether a man is obese, education affects both sexes. The team at the National Center for Health Statistics writes, “Among men, obesity prevalence is generally similar at all income levels, with a tendency to be slightly higher at higher income levels.”

14 Dec 2010

ISTA commences bepotastine besilate nasal spray Phase 2 study in seasonal allergic rhinitis

ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting with allergic rhinitis caused by one of the most potent seasonal allergy triggers, Mountain Cedar pollen.

14 Dec 2010

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.

14 Dec 2010

Institute for Child and Family Health recognized for exemplary implementation of evidence-based interventions

Institute for Child and Family Health (ICFH), a non-profit organization that offers prevention and treatment programs for children and families in Miami-Dade County, today announced it has received the prestigious SAMHSA 2010 Science and Service Awards. This award recognizes exemplary implementation of evidence-based interventions that have been shown to prevent and/or treat mental illnesses and substance abuse.

14 Dec 2010

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

14 Dec 2010

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.

14 Dec 2010

Workplace interactions may educate people about organ donation process

Face-to-face workplace interactions may be the best way to educate and encourage people to consider becoming organ donors, according to new research from Purdue University.

14 Dec 2010

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues.

14 Dec 2010

FDA accepts for filing Pacira's EXPAREL NDA for postsurgical pain management

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, announced today that the New Drug Application (NDA) for EXPAREL™, a long-acting bupivacaine for postsurgical pain management, has been accepted for filing by the U.S. Food and Drug Administration (FDA).

14 Dec 2010

Strength training exercise program for seniors provides sustained cognitive, economic benefits

A one-year follow-up study on seniors who participated in a strength training exercise program shows sustained cognitive benefits as well as savings for the healthcare system. The research, conducted at the Centre for Hip Health and Mobility at Vancouver Coastal Health and the University of British Columbia, is published today in the Archives of Internal Medicine.

14 Dec 2010

Rheumatologists raise awareness on early diagnosis and treatment of inflammatory arthritis

In people who develop symptoms of inflammatory arthritis, early diagnosis and treatment can have a significant impact on the course of disease—in some cases even preventing deformity and loss of function from rheumatoid arthritis, according to an article in the December issue of JCR: Journal of Clinical Rheumatology.

14 Dec 2010

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.

14 Dec 2010

Alzheimer Society applauds House of Commons motion calling on government to address dementia in Canada

The Alzheimer Society of Canada applauds a motion passed Friday by the House of Commons calling on the Federal Government to "address the rising financial and human costs of Alzheimer's disease and other forms of dementia in Canada."

14 Dec 2010

Response Genetics presents two gene expression analysis for personalized cancer tharapy selection

Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced the results of two separate analyses at national medical conferences.

14 Dec 2010

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.

14 Dec 2010

UnitedHealthcare's care management solution will improve diabetes prescription drug adherence: Study

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that UnitedHealthcare's innovative care management solution in the Phoenix market will improve diabetes prescription drug adherence. According to the recent West Health Plan Analysis, the use of non-physician, credentialed providers is intended to create virtual medical homes that allow non-traditional providers, such as pharmacists, wellness coordinators and lifestyle coaches, to recommend and coordinate necessary prescription adjustments.

14 Dec 2010

Medical Condition News

Poverty and obesity links

ISTA commences bepotastine besilate nasal spray Phase 2 study in seasonal allergic rhinitis

Tolerx commences TRX518 Phase 1 trial in malignant melanoma

Institute for Child and Family Health recognized for exemplary implementation of evidence-based interventions

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Workplace interactions may educate people about organ donation process

Lexicon reports top-line results from LX2931 Phase 2a study in rheumatoid arthritis

FDA accepts for filing Pacira's EXPAREL NDA for postsurgical pain management

Strength training exercise program for seniors provides sustained cognitive, economic benefits

Rheumatologists raise awareness on early diagnosis and treatment of inflammatory arthritis

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Alzheimer Society applauds House of Commons motion calling on government to address dementia in Canada

Response Genetics presents two gene expression analysis for personalized cancer tharapy selection

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

UnitedHealthcare's care management solution will improve diabetes prescription drug adherence: Study

Grey's Anatomy features patient with von Hippel-Lindau disease

Pruritic nodules and aluminium allergy arise after vaccinations or treatments for allergies

Scientists discover new way in which HPV triggers cancer

Chinese hospital uses UNIQUE radiotherapy system to treat cancer patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News